Ex vivo tumor testing platform for predicting clinical response to platinum-based therapy in patients with high grade serous ovarian cancer

被引:0
|
作者
Ottevanger, P. B.
Kroep, Judith R.
van Persijn-van Meerten, Els L.
van Altena, Anne M.
de Kroon, Cornelis
Ceton, Lieke J.
Montero, Marta G.
van der Meer, Donny J.
Vader, Willemijn
机构
[1] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands
[4] VitroScan BV, Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5563
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Straightforward molecular tests for predicting response and non-response to platinum-based neoadjuvant therapy in high-grade serous ovarian cancer patients
    Imyanitov, E. N.
    Sokolenko, A.
    Gorodnova, T.
    Bizin, I. V.
    Kuligina, E. S.
    Kotiv, K.
    Romanko, A.
    Ermachenkova, T.
    Ivantsov, A. O.
    Preobrazhenskaya, E.
    Sokolova, T.
    Aleksakhina, S.
    Broyde, R.
    Berlev, I.
    ANNALS OF ONCOLOGY, 2021, 32 : S748 - S748
  • [2] Predicting Ovarian Cancer Patients' Clinical Response to Platinum-Based Chemotherapy by Their Tumor Proteomic Signatures
    Yu, Kun-Hsing
    Levine, Douglas A.
    Zhang, Hui
    Chan, Daniel W.
    Zhang, Zhen
    Snyder, Michael
    JOURNAL OF PROTEOME RESEARCH, 2016, 15 (08) : 2455 - 2465
  • [3] Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy Resistance in Patients With High-grade Serous Ovarian Cancer
    Cocchi, Sara
    Lopacinska-Jorgensen, Joanna
    Hogdall, Estrid, V
    ANTICANCER RESEARCH, 2024, 44 (11) : 4691 - 4707
  • [4] Intratumoral and Peritumoral Radiomics for Predicting the Prognosis of High-grade Serous Ovarian Cancer Patients Receiving Platinum-Based Chemotherapy
    Huang, Xiaoyu
    Huang, Yong
    Liu, Kexin
    Zhang, Fenglin
    Zhu, Zhou
    Xu, Kai
    Li, Ping
    ACADEMIC RADIOLOGY, 2025, 32 (02) : 877 - 887
  • [5] A Tumor-Genetic Signature of Patients' Prognosis and Response to a Platinum-Based Treatment in High-Grade Ovarian Cancer
    Roncato, R.
    Toffoli, G.
    Montico, M.
    Gagno, S.
    Garziera, M.
    Poletto, E.
    De Mattia, E.
    Sorio, R.
    Canzonieri, V.
    Giorda, G.
    Cecchin, E.
    PUBLIC HEALTH GENOMICS, 2016, 19 : 7 - 7
  • [6] Homologous recombination deficiency (HRD) score predicts response to platinum-based chemotherapies in Chinese high grade serous ovarian cancer patients
    Wen, Hao
    Feng, Zheng
    Yuan, Wuzhou
    Zhou, Xiaoyan
    Wu, Xiaohua
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S108 - S109
  • [7] Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
    Ahn, Byungsoo
    Moon, Damin
    Kim, Hyun-Soo
    Lee, Chung
    Cho, Nam Hoon
    Choi, Heung-Kook
    Kim, Dongmin
    Lee, Jung-Yun
    Nam, Eun Ji
    Won, Dongju
    An, Hee Jung
    Kwon, Sun Young
    Shin, Su-Jin
    Jung, Hye Ra
    Kwon, Dohee
    Park, Heejung
    Kim, Milim
    Cha, Yoon Jin
    Park, Hyunjin
    Lee, Yangkyu
    Noh, Songmi
    Lee, Yong-Moon
    Choi, Sung-Eun
    Kim, Ji Min
    Sung, Sun Hee
    Park, Eunhyang
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [8] Elucidating mechanisms involved in long-term response to platinum-based chemotherapy in high-grade serous ovarian cancer.
    Lheureux, Stephanie
    Yang, Cindy
    Shaw, Patricia
    Clarke, Blaise
    Tsao, Julissa
    Karakasis, Katherine
    Butler, Marcus
    Salman, Noor
    Dowar, Mark
    Xu, Jing
    Poulain, Laurent
    Ohashi, Pamela S.
    Pugh, Trevor
    Oza, Amit
    CLINICAL CANCER RESEARCH, 2016, 22
  • [9] Prediction of Platinum-based Chemotherapy Response in Advanced High-grade Serous Ovarian Cancer: ADC Histogram Analysis of Primary Tumors
    Lu, Jing
    Li, Hai Ming
    Cai, Song Qi
    Zhao, Shu Hui
    Ma, Feng Hua
    Li, Yong Ai
    Ma, Xiao Liang
    Qiang, Jin Wei
    ACADEMIC RADIOLOGY, 2021, 28 (03) : e77 - e85
  • [10] Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
    Feng, Zheng
    Shao, Di
    Cai, Yuhang
    Bi, Rui
    Ju, Xingzhu
    Chen, Dongju
    Song, Chengcheng
    Chen, Xiaojun
    Li, Jin
    An, Na
    Li, Yunjin
    Zhou, Qing
    Xiu, Zhihui
    Zhu, Shida
    Wu, Xiaohua
    Wen, Hao
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)